Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification - Summary - MDSpire

Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification

  • By

  • Mingzhe Xu

  • Kuiyuan Liu

  • Shouning Zhang

  • Haotian Li

  • Renzhi Zhang

  • Chunmiao Xu

  • Junhui Yuan

  • Yue Wu

  • Dan Wu

  • Xuejun Chen

  • Jinrong Qu

  • June 9, 2026

  • 0 min

Share

Objective:

To correct the funding statement in the original article regarding financial support for the research.

Key Findings:
  • The funding statement was updated to include the Henan Province Central Plains Talent Program, which was previously omitted.
Interpretation:

Limitations:
Conclusion:

The original article has been updated to reflect the correct funding information.

Original Source(s)

Correction: Time-dependent diffusion MRI for noninvasive molecular subtype differentiation and biological correlation in breast cancer: emphasizing the emerging three-tier HER2 classification

  • by Mingzhe Xu, Kuiyuan Liu, Shouning Zhang, Haotian Li, Renzhi Zhang, Chunmiao Xu, Junhui Yuan, Yue Wu, Dan Wu, Xuejun Chen, Jinrong Qu

  • June 9, 2026

Related Content

Baseline vs. on-treatment heart failure with preserved ejection fraction (HFpEF) in a real world cardio-oncology clinic: observational analysis of cancer therapy-related cardiovascular toxicity incidence and cancer treatment implications

This Week’s CGT News: Promising Data for In Vivo CAR T

Legend and Kelonia reveal 100 percent response rates in phase 1 trials, dual CAR T opens doors for kidney transplant patients, and iPDSC therapy beefs up failing hearts

  • June 8, 2026

  • 6 min
Case Report: early regression and bladder-intact survival after limited-course immunotherapy-based systemic therapy in two patients with clinically staged bulky muscle-invasive bladder cancer